+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Resorbable Pericardial Membrane Market by Application, Material, Product Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Resorbable Pericardial Membrane Market by Application, Material, Product Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Resorbable Pericardial Membrane Market by Application, Material, Product Type, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084704
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Setting the Stage with Resorbable Pericardial Membrane Innovations

Resorbable pericardial membranes have emerged as a cornerstone technology in modern surgical interventions, offering a biocompatible solution that naturally integrates into human tissue. These advanced membranes provide temporary support and controlled degradation, facilitating tissue repair while minimizing the need for removal procedures. Over the past decade, incremental improvements in crosslinking methods, sterilization techniques, and raw material sourcing have bolstered clinical outcomes, driving adoption among cardiac, neurological, and thoracic surgeons.

The convergence of regulatory approvals, growing clinician familiarity, and patient demand for minimally invasive procedures has positioned resorbable pericardial membranes at the forefront of cardiovascular and reconstructive therapies. Additionally, the rise of personalized medicine and the trend toward tailored biomaterials compositions have expanded the scope of applications, paving the way for innovative indications beyond traditional pericardial repair.

Simultaneously, healthcare payers are increasingly recognizing the cost-efficiency of resorbable membranes, as reduced reoperation rates and shorter hospital stays translate into measurable economic benefits. Government initiatives promoting minimally invasive and value-based care further reinforce the membrane’s strategic value proposition. Against this backdrop, stakeholders across the ecosystem are reassessing supply chain dynamics, production scalability, and intellectual property portfolios to capture the momentum of this high-growth segment. With this groundwork in place, the market is primed for the next wave of innovation and expansion.

Catalysts Redefining the Resorbable Pericardial Membrane Landscape

The resorbable pericardial membrane landscape is being redefined by breakthroughs in material science, regulatory realignments, and evolving clinical pathways. Novel decellularization and crosslink-free technologies have enhanced biocompatibility and reduced inflammatory responses, motivating surgeons to adopt these membranes in increasingly complex procedures. Parallel advancements in 3D bioprinting and computational modeling are enabling custom geometries and patient-specific designs, which were once the realm of theoretical research.

Regulatory bodies are embracing these innovations through streamlined pathways that balance rigorous safety standards with expedited approvals for devices demonstrating clear clinical benefits. This shift has encouraged manufacturers to accelerate product launches and expand their pipelines. At the same time, the digital surgery revolution-featuring augmented reality guidance and robotic assistance-has created new opportunities for membranes tailored to minimally invasive delivery systems.

Patient expectations and healthcare economics are also driving transformation. A growing emphasis on faster recovery, reduced postoperative pain, and lower total cost of care has made resorbable membranes a competitive alternative to synthetic or permanent implants. Strategic alliances between academic centers, device manufacturers, and specialty contract research organizations are fostering collaborative ecosystems, turning isolated innovations into scalable solutions. As a result, the stage is set for sustained market disruption and rapid adoption across diverse clinical domains.

Assessing the 2025 US Tariffs and Their Industry-Wide Repercussions

The implementation of new United States tariffs effective in early 2025 is poised to exert a cumulative impact on the resorbable pericardial membrane market. Higher duties on imported biomaterials derived from bovine, porcine, and equine pericardium will increase input costs for domestic manufacturers that rely on global supply chains. This cost pressure will likely cascade through distributors and healthcare providers, compelling stakeholders to reassess pricing strategies and procurement contracts.

In response to the tariff environment, some manufacturers may pursue nearshoring of raw material processing or negotiate long-term fixed-price agreements with suppliers outside the tariff’s scope. Others will explore duty drawback programs and tariff engineering solutions to mitigate the financial burden. However, smaller innovators without established logistics networks may face significant challenges, potentially delaying product launches or reducing research investments.

Across the value chain, the tariff-induced cost escalation will intensify competitive pressures. Healthcare systems operating under fixed reimbursement models may push back on price increases, prompting companies to enhance operational efficiencies or accelerate the development of lower-cost synthetic alternatives. Meanwhile, multinational suppliers with diversified manufacturing footprints may gain a strategic edge, being able to reallocate production to tariff-exempt jurisdictions.

Overall, the 2025 tariff measures will serve as a catalyst for supply chain realignment, strategic partnerships, and renewed focus on cost containment, fundamentally reshaping the industry’s competitive landscape.

Dissecting Market Dynamics Through Targeted Segmentation

Dissecting the market through targeted segmentation reveals nuanced demand drivers and high-growth opportunities across applications, materials, product configurations, end-user types, and distribution channels. In terms of application, cardiac surgery remains the bedrock segment, encompassing coronary artery bypass grafting, structural repairs such as atrial septal defect and patent foramen ovale closure, and valve replacement procedures. Neurological usage focuses on dural substitute, while thoracic interventions include esophageal surgery and tracheal reconstruction.

Material preferences segregate the market between bovine pericardium, equine pericardium, and porcine pericardium, each offering distinct mechanical properties and immunogenic profiles. Product types are further defined as film, patch, and sheet formats, with sheets categorized by thickness ranges of less than 0.5 mm, from 0.5 to 1 mm, and more than 1 mm to address variable handling and structural requirements.

End users span ambulatory surgical centers-subdivided into dedicated cardiac centers and general ambulatory facilities-traditional hospitals with specialized cardiac units and general care wings, as well as specialty clinics focused on minimally invasive procedures. Distribution channel analysis underscores a balance between direct tenders to large health systems, partnerships with medical device distributors, and emerging online platforms enabling expedited order fulfillment and smaller-volume purchasing.

By mapping revenue flows and adoption rates across these axes, industry participants can pinpoint underpenetrated segments, refine go-to-market strategies, and align R&D investments with evolving clinical needs.

Geographic Vantage Points Shaping Regional Growth Trajectories

Understanding regional nuances is essential for capitalizing on growth pockets and mitigating market challenges. In the Americas, well-established reimbursement frameworks and high procedural volumes underpin stable demand, while localized innovation hubs and manufacturing centers support rapid product deployment. Pricing pressures in this region are moderated by bundled payment initiatives and value-based contracts that reward improved clinical outcomes.

Europe, the Middle East & Africa presents a mosaic of regulatory landscapes and healthcare funding models. Western European markets benefit from harmonized approvals and cross-border distribution efficiencies, whereas emerging markets in the Middle East and Africa are characterized by infrastructure constraints and evolving procurement practices. Diverse clinical guidelines and varying surgeon preferences drive a need for adaptable product portfolios and tailored market entry approaches.

Asia-Pacific is defined by its fast-growing surgical volumes, increasing government healthcare expenditure, and rising patient awareness. Cost sensitivity remains a key factor, prompting manufacturers to explore local partnerships and technology transfer agreements. As domestic production capabilities expand and regional regulatory frameworks mature, Asia-Pacific is poised to become both a major consumer and an exporter of resorbable pericardial membranes.

By aligning product positioning, pricing models, and stakeholder engagement plans with these regional dynamics, market participants can optimize resource allocation and accelerate penetration across varied geographies.

Competitive Outlook Featuring Pioneers and Emerging Challengers

Competitive intensity in the resorbable pericardial membrane market is driven by a mix of established medical device leaders, specialty biomaterials firms, and agile emerging players. Large multinational corporations leverage extensive clinical trial networks, robust regulatory expertise, and deep commercial channels to maintain leadership in core cardiac surgery applications. Their strategies include incremental product enhancements, strategic acquisitions to expand biomaterial portfolios, and investments in next-generation membrane technologies.

Mid-tier innovators and startups, on the other hand, are carving out niches through novel decellularization processes, synthetic pericardium alternatives, and proprietary crosslinking chemistries. These challengers often foster close collaborations with academic research centers and physician thought leaders to accelerate clinical validation. By focusing on differentiated performance attributes-such as enhanced tensile strength, accelerated integration rates, or reduced inflammatory response-they are gradually expanding into adjacent neurosurgical and thoracic segments.

Distribution partnerships with medical device distributors and purchasing alliances provide additional market access advantages, enabling smaller companies to achieve scale without building extensive field forces. At the same time, direct-to-hospital tendering remains a critical channel for high-value contracts, especially in markets with centralized procurement. Online platforms have started to play a supplementary role, offering streamlined ordering and smaller-volume access for niche applications.

Overall, success in this competitive landscape requires a dual focus on technological differentiation and channel optimization, supported by strategic collaborations and adaptive commercialization models.

Strategic Imperatives for Leadership in a Rapidly Evolving Market

Industry leaders should prioritize sustained investment in R&D to advance membrane performance and broaden clinical indications. Pursuing decellularization and crosslink-free innovations can reduce immunogenicity and differentiate offerings in a crowded marketplace. Expanding the material portfolio to include equine and porcine variants, alongside synthetic alternatives, will address surgeon preferences and supply chain contingencies.

Diversification across application segments is essential. While cardiac surgery continues to drive volume, neurological and thoracic applications represent high-margin growth areas. Collaborating with key opinion leaders and early-adopter centers of excellence can accelerate adoption in these segments. Simultaneously, cultivating strong relationships with payers to validate health economic benefits will support favorable reimbursement decisions.

Geographic expansion strategies should emphasize local partnerships, technology transfer agreements, and regulatory alignment to navigate regional complexities effectively. Mitigating tariff exposure through localized manufacturing or duty management programs will preserve margin integrity. Embracing digital sales channels and data-driven marketing will enhance customer engagement and streamline procurement processes.

Finally, exploring strategic alliances, joint ventures, or targeted acquisitions can fill portfolio gaps and bolster market access. By combining innovation with operational excellence and distribution agility, industry leaders can secure sustainable competitive advantage in this evolving market.

Rigorous Methodology Underpinning Robust Market Insights

Our research methodology integrates comprehensive secondary data collection with targeted primary engagements to ensure robust and reliable insights. Secondary sources include peer-reviewed journals, regulatory filings, company annual reports, healthcare reimbursement databases, and published conference proceedings. These sources establish a foundational understanding of market dynamics, clinical evidence, and technology trends.

Primary research comprises in-depth interviews with cardiovascular, neurological, and thoracic surgeons, procurement executives, and payers across key regions. Feedback from these stakeholders validates market drivers, adoption barriers, and clinical outcome priorities. Quantitative data from institutional purchasing records and device registries further refines our segmentation analyses.

We apply triangulation techniques to reconcile data from multiple sources, ensuring consistency and accuracy. Our segmentation framework dissects the market by application, material type, product format, end-user category, and distribution channel. Regional modeling incorporates country-level healthcare expenditure, procedural volume forecasts, and policy environments.

Quality control measures include peer review by subject matter experts, cross-validation of data points, and iterative refinement of assumptions. While our approach emphasizes depth and rigor, we acknowledge potential limitations related to emerging technologies that have yet to achieve widespread commercialization. Nonetheless, this methodology provides a comprehensive and actionable view of the resorbable pericardial membrane market.

Synthesis of Key Findings and Future Outlook

The resorbable pericardial membrane market stands at a pivotal juncture, driven by material innovations, digital surgery integration, and shifting regulatory paradigms. Technological advancements in decellularization and crosslink-free chemistries have enhanced clinical performance, while tariff dynamics and cost-containment pressures are reshaping supply chains. Segmentation analyses highlight opportunities across cardiac, neurological, and thoracic applications, with material and product format choices enabling targeted value propositions.

Regional insights underscore the importance of aligning strategies with local reimbursement models, regulatory landscapes, and manufacturing capabilities. Competitive analyses reveal a dual landscape of large incumbents fortifying core franchises and agile challengers pursuing specialized niches. Actionable recommendations emphasize R&D investment, geographic diversification, supply chain resilience, and strategic alliances.

As the market evolves, stakeholders who balance technological differentiation with operational efficiency and customer-centric engagement will capture the greatest value. By leveraging our comprehensive insights, industry participants can navigate complexities, anticipate emerging trends, and position themselves for sustained growth in the resorbable pericardial membrane sector.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Cardiac Surgery
      • Coronary Artery Bypass Grafting
      • Structural Repairs
        • Atrial Septal Defect
        • Patent Foramen Ovale Closure
      • Valve Replacement
    • Neurological Applications
      • Dural Substitute
    • Thoracic Surgery
      • Esophageal Surgery
      • Tracheal Reconstruction
  • Material
    • Bovine Pericardium
    • Equine Pericardium
    • Porcine Pericardium
  • Product Type
    • Film
    • Patch
    • Sheet
      • 0.5 To 1mm
      • Less Than 0.5mm
      • More Than 1mm
  • End User
    • Ambulatory Surgical Centers
      • Cardiac Centers
      • General Ambulatory Surgical Centers
    • Hospitals
      • Cardiac Centers
      • General Hospitals
    • Specialty Clinics
  • Distribution Channel
    • Direct Tender
    • Distributors
    • Online Channels
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Baxter International Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Edwards Lifesciences Corporation
  • W. L. Gore & Associates, Inc.
  • CryoLife, Inc.
  • Aziyo Biologics, Inc.
  • Tissue Regenix Group plc
  • Admedus Limited
  • Lepu Medical Technology Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Resorbable Pericardial Membrane Market, by Application
8.1. Introduction
8.2. Cardiac Surgery
8.2.1. Coronary Artery Bypass Grafting
8.2.2. Structural Repairs
8.2.2.1. Atrial Septal Defect
8.2.2.2. Patent Foramen Ovale Closure
8.2.3. Valve Replacement
8.3. Neurological Applications
8.3.1. Dural Substitute
8.4. Thoracic Surgery
8.4.1. Esophageal Surgery
8.4.2. Tracheal Reconstruction

9. Resorbable Pericardial Membrane Market, by Material
9.1. Introduction
9.2. Bovine Pericardium
9.3. Equine Pericardium
9.4. Porcine Pericardium

10. Resorbable Pericardial Membrane Market, by Product Type
10.1. Introduction
10.2. Film
10.3. Patch
10.4. Sheet
10.4.1. 0.5 To 1mm
10.4.2. Less Than 0.5mm
10.4.3. More Than 1mm

11. Resorbable Pericardial Membrane Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.2.1. Cardiac Centers
11.2.2. General Ambulatory Surgical Centers
11.3. Hospitals
11.3.1. Cardiac Centers
11.3.2. General Hospitals
11.4. Specialty Clinics

12. Resorbable Pericardial Membrane Market, by Distribution Channel
12.1. Introduction
12.2. Direct Tender
12.3. Distributors
12.4. Online Channels

13. Americas Resorbable Pericardial Membrane Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina

14. Europe, Middle East & Africa Resorbable Pericardial Membrane Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland

15. Asia-Pacific Resorbable Pericardial Membrane Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan

16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Baxter International Inc.
16.3.2. Johnson & Johnson
16.3.3. Medtronic plc
16.3.4. Edwards Lifesciences Corporation
16.3.5. W. L. Gore & Associates, Inc.
16.3.6. CryoLife, Inc.
16.3.7. Aziyo Biologics, Inc.
16.3.8. Tissue Regenix Group plc
16.3.9. Admedus Limited
16.3.10. Lepu Medical Technology Co., Ltd.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

List of Figures
FIGURE 1. RESORBABLE PERICARDIAL MEMBRANE MARKET MULTI-CURRENCY
FIGURE 2. RESORBABLE PERICARDIAL MEMBRANE MARKET MULTI-LANGUAGE
FIGURE 3. RESORBABLE PERICARDIAL MEMBRANE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. RESORBABLE PERICARDIAL MEMBRANE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. RESORBABLE PERICARDIAL MEMBRANE MARKET, FPNV POSITIONING MATRIX, 2024

List of Tables
TABLE 1. RESORBABLE PERICARDIAL MEMBRANE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ATRIAL SEPTAL DEFECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DURAL SUBSTITUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ESOPHAGEAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY TRACHEAL RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY BOVINE PERICARDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY EQUINE PERICARDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PORCINE PERICARDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY FILM, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY 0.5 TO 1MM, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY LESS THAN 0.5MM, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MORE THAN 1MM, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY GENERAL AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 74. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 76. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 77. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 78. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 79. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 80. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 82. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 84. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 85. CANADA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 88. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 91. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 92. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 94. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 149. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 152. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 153. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 155. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 158. GERMANY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 161. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 162. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 163. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 164. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 165. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 167. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 169. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 170. FRANCE RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 185. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 186. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 187. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 188. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 189. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 191. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 193. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 194. ITALY RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 197. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 198. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 199. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 200. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 201. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 203. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 245. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 246. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 247. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 248. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 249. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 251. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 253. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 269. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 270. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 271. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 272. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 273. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 275. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 277. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 278. QATAR RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 281. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 282. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 283. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 284. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 285. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEET, 2018-2030 (USD MILLION)
TABLE 287. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 289. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 290. FINLAND RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY STRUCTURAL REPAIRS, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY THORACIC SURGERY, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN RESORBABLE PERICARDIAL MEMBRANE MARKET SIZE, BY SHEE

Companies Mentioned

The companies profiled in this Resorbable Pericardial Membrane market report include:
  • Baxter International Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Edwards Lifesciences Corporation
  • W. L. Gore & Associates, Inc.
  • CryoLife, Inc.
  • Aziyo Biologics, Inc.
  • Tissue Regenix Group plc
  • Admedus Limited
  • Lepu Medical Technology Co., Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Collagen Dental Membrane Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Collagen Dental Membrane Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
ECMO Hollow Fiber Membrane Market by Product Type, Material, Application, End User - Global Forecast to 2030 - Product Image

ECMO Hollow Fiber Membrane Market by Product Type, Material, Application, End User - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
Reverse Osmosis Membrane Market by Module Design, Membrane Type, Operating Pressure, Application, End Use Industry - Global Forecast to 2030 - Product Image

Reverse Osmosis Membrane Market by Module Design, Membrane Type, Operating Pressure, Application, End Use Industry - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Gas Separation Membranes - Global Strategic Business Report - Product Image

Gas Separation Membranes - Global Strategic Business Report

  • Report
  • 565 Pages
  • Global
From
Membranes Market by Material (Polymeric, Ceramic), Technology (Reverse Osmosis (RO), Ultrafiltration (UF), Microfiltration (MF), Nanofiltration (NF)), Application (Water & Wastewater Treatment, Industrial Processing), Region - Forecast to 2029 - Product Image

Membranes Market by Material (Polymeric, Ceramic), Technology (Reverse Osmosis (RO), Ultrafiltration (UF), Microfiltration (MF), Nanofiltration (NF)), Application (Water & Wastewater Treatment, Industrial Processing), Region - Forecast to 2029

  • Report
  • 258 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.